Blog

Parade Technologies Reports Fourth Quarter and Fiscal 2022 Financial Results

Financial Highlights: Q422 consolidated revenue US$101.45 million, compared with US$194.26 million in the year-ago quarter Q422 consolidated net income US$14.48 million; Basic and Fully diluted after-tax EPS US$0.18 (NT$5.67) and US$0.18 (NT$5.60), respectively SAN JOSE, Calif.--(BUSINESS WIRE)--Parade Technologies, Ltd. (Taipei Exchange: 4966.TWO), a leading high-speed interface IC supplier, today announced…
Leer más...

Monument Group Expands its European Presence with Amsterdam Office

BOSTON & LONDON & AMSTERDAM--(BUSINESS WIRE)--Monument Group, a global capital advisory and fundraising partner in alternative investments, today announced the opening of a new office in Amsterdam. Monument Group Netherlands B.V., which is fully licensed in the Netherlands and passported throughout the European Union, will support Monument Group’s growing European…
Leer más...

Former Chairman of Velodyne, Michael Dee, Suggests Shareholders “Abstain” on the Ouster Merger Vote February 10th until Outstanding Issues Resolved and Terms Improved

Velodyne Board Released Two Critical Letters from the Former Chairman Last Week Cites Lack of Timely Disclosure of New Directors and Calls for their Replacement Calls for Disclosure of Audited Ouster Fourth Quarter and Full Year Financial Results Notes that Velodyne Warrant Holders have been Treated Unfairly and Deserve Recompense…
Leer más...

Xponential Fitness, Inc. Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders

IRVINE, Calif.--(BUSINESS WIRE)--Xponential Fitness, Inc. (NYSE: XPOF) (the “Company”, “Xponential Fitness” or “we”), the largest global franchisor of boutique fitness brands, today announced the pricing of the previously announced underwritten public offering of 5,000,000 shares of the Company’s Class A common stock (the “Offering”) by certain of the Company’s existing…
Leer más...

M-Files Acquires No-Code Document Automation Company Ment

Global Information Management Leader Strengthens Platform to Deliver Best-in-Class Document Management and Automation Capabilities AUSTIN, Texas--(BUSINESS WIRE)--#B2B--M-Files, a global leader in information management, today announced that the company has acquired Ment (formerly Contract Mill Oy), a leading no-code document automation technology company based in Espoo, Finland. With this acquisition, M-Files…
Leer más...

Trellix Launches Xtend Global Channel Partner Program

Distinctive partner-first approach is designed to accelerate adoption of the Trellix XDR platform and increase cyber resilience for customers SAN JOSE, Calif.--(BUSINESS WIRE)--Trellix, the cybersecurity company delivering the future of extended detection and response (XDR), today announced the launch of its Trellix Xtend Global Channel Partner Program. Xtend was developed…
Leer más...

Former Chairman of Velodyne, Michael Dee, Suggests Shareholders “Abstain” on the Ouster Merger Vote February 10th until Outstanding Issues Resolved and Terms Improved

Velodyne Board Released Two Critical Letters from the Former Chairman Last Week Cites Lack of Timely Disclosure of New Directors and Calls for their Replacement Calls for Disclosure of Audited Ouster Fourth Quarter and Full Year Financial Results Notes that Velodyne Warrant Holders have been Treated Unfairly and Deserve Recompense…
Leer más...

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in PLDT Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--$PHI #PHI--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PLDT Inc. (“PLDT” or “the Company”) (NYSE: PHI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.…
Leer más...

Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock

SAN DIEGO--(BUSINESS WIRE)--$LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its voting common stock at a price to the public of $4.00 per share.…
Leer más...